Cowen Reiterates Outperform Rating on Exact Sciences (EXAS) Following MCED Test Data
Tweet Send to a Friend
Cowen analyst Dan Brennan reiterated an Outperform rating and $67.00 price target on Exact Sciences (NASDAQ: EXAS) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
